Phenylephrine Injectable Solution Recalled Over Sterility Assurance Failure
Central Admixture Pharmacy Services recalls 13,953 bags of phenylephrine injectable solution nationwide due to FDA concerns about sterility assurance identified during inspection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable product with sterility assurance concerns. No illnesses or injuries have been reported in the source. Per the severity rubric, Class II recalls without reported illness and with theoretical hazards score at most High (3).
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 13,953 bags of phenylephrine added to 0.9% sodium chloride injectable solution (NDC 71285-7025-1), distributed nationwide.
The recall was initiated after an FDA inspection raised questions about whether the product maintains sterility assurance, which is critical for injectable medications. No illnesses or injuries have been reported.
The affected lots have expiration dates ranging from April 28, 2023 to June 29, 2023. Individuals and healthcare facilities using this product should stop immediately and contact their healthcare provider or pharmacist about alternatives. Unused product should be returned to Central Admixture Pharmacy Services or disposed of per FDA guidance.
The recalled product
- Product
- PHENYLephrine added to 0.9% sodium chloride, 20 mg/250 mL* (80 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7025-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Injectable Solution
- Affected units
- 13,953
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 37-883074
- Exp 04/28/2023
- 37-883237
- 37-883238
- Exp 04/30/2023
- 37-883940
- Exp 05/02/2023
- 37-884271
- Exp 05/03/2023
- 37-884749
- 37-884751
- Exp 05/05/2023
- 37-885338
- Exp 05/08/2023
- 37-885756
- Exp 05/09/2023
- 37-886272
- Exp 05/11/2023
- 37-887512
- Exp 05/16/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 108 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 108 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15